CSW Industrials vs Fuller H B
CSW and FUL side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CSW and FUL compare
CSW Industrials is the larger company, worth 1.7 times as much as Fuller H B ($4.6B against $2.7B).
On earnings, Fuller H B is cheaper: it trades at 13.7× trailing earnings, against 36.4× for CSW Industrials.
CSW Industrials grew revenue faster over the last twelve months (30.0% versus 1.5% for Fuller H B).
CSW Industrials keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with 5.6% at Fuller H B.
Both pay dividends: CSW Industrials yields 0.31% and Fuller H B 2.0%.
Fuller H B scores higher on the StockData Score (18 against 10 for CSW Industrials), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CSW | FUL |
|---|---|---|
| Size and price | ||
| Market cap | $4.6B | $2.7B |
| Share price | $283.04 | $49.29 |
| Change, 1 year | 15.5% | −14.8% |
| Change, 5 years | 105% | −35.6% |
| Beta (5Y) | 1.01 | 0.95 |
| Employees | 2,700 | 7,100 |
| StockData Score | ||
| Total score | 10 | 18 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 3 (better) | 2 |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 36.4× | 13.7× (better) |
| P/S | 3.7× | 0.7× (better) |
| P/B | – | 1.2× |
| EV/EBITDA | 25.2× | 7.9× (better) |
| P/FCF | 26.0× (better) | 26.5× |
| PEG | 13.89 | – |
| FCF yield | 3.8% (better) | 3.8% |
| Fair value | $208.91 | $102.06 |
| Margin of safety | −35.5% | 51.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 30.0% (better) | 1.5% |
| Revenue growth, 5Y average | 20.9% (better) | 4.5% |
| Net income growth (TTM) | −11.2% | 72.2% (better) |
| EPS growth (TTM) | −8.7% | 71.8% (better) |
| EPS growth, 5Y average | 20.4% (better) | 3.1% |
| Profitability | ||
| Gross margin | 42.1% (better) | 32.3% |
| Operating margin | 16.9% | – |
| Net margin | 10.2% (better) | 5.6% |
| FCF margin | 14.2% (better) | 2.8% |
| Return on equity | – | 9.6% |
| Financial health | ||
| Debt / equity | – | 0.95 |
| Net debt / EBITDA | 3.43 | 3.35 (better) |
| Current ratio | 2.35 (better) | 1.82 |
| Altman Z-score | 3.88 (better) | 1.85 |
| Piotroski F-score | 3 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.31% | 2.0% (better) |
| Payout ratio | 14.7% | 26.2% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 7.4% |
| Buyback yield | 3.2% (better) | 1.8% |
| Shareholder yield | 3.5% | 3.8% (better) |
| Ownership | ||
| Held by institutions | 101% | 104% |
| Held by insiders | 1.4% | 0.65% |
| Insider net buying, 12 months | −$8.7M | $853K (better) |
| Short interest, % of float | 6.3% | 4.1% |
Go deeper
- CSW stock overview
- CSW income statement
- CSW valuation and score
- FUL stock overview
- FUL income statement
- FUL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.